Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-03-01 @ 1:49 AM
Study NCT ID:
NCT02110394
Status:
COMPLETED
Last Update Posted:
2016-07-06
First Post:
2014-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia
Sponsor:
Astellas Pharma Europe B.V.
Organization: